Posted December 13, 2005
CeNeRx BioPharma Names Chief Medical Officer
Post a comment
Print this storyE-mail story
Share
RESEARCH TRIANGLE PARK —
CeNeRx Biophrama, a startup focused on central nervous systems disorders, has named Atul Pande, MD, as its chief medical officer.
Pande will be tasked with leading CeNeRx research and development efforts.
He most recently served as vice president for neurosciences at Pfizer. He has a total of 13 years of experience, having also worked for Eli Lilly and Parke-Davis. At Pfizer, he led development of a new drug for the treatment of neuropathic pain and epilepsy. CeNeRx recently closed on $18.5 million in financing.
CeNeRx: www.www.cenerx.com
Copyright 2010 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Featured
Hot Off The Wire
- Hot Off the Wire – AT&T CEO’s pay soars to $20.2M; Analyst downgrades Yahoo; Motorola adds Bing to smartphones
- Hot Off the Wire – Net naming agency reconsiders ‘xxx’ domain; Huge botnet taken down; Google to digitize historic books in Rome, Florence
- Hot Off the Wire – MySpace plans makeover after exec shakeup; Early PC designer wins Turning technology award; Cisco competitor share’s jump
Venture & Innovation
- CED picks nine more companies to present at venture conference
- Venture Briefs – A top VC uses blog to generate wider dealfow; CA pays $350M for cloud computing firm; Battery closes on $750M fund
- Venture briefs – 10th birthday for ‘dot-com bubble’ peak; ‘Startup Bus’ teams entrepreneurs for ideas; Carried interest debate is back; Weebly adds theme site creation tool
E-mail Preferences
